Fixed drug eruption and generalized bullous fixed drug eruption: Insights from an analysis of the FDA Adverse Event Reporting System

被引:1
|
作者
Shrestha, P. [1 ]
Stone, Jr C. A. [1 ,2 ]
Phillips, E. J. [1 ,2 ,3 ]
机构
[1] Vanderbilt Univ, Dept Med, Div Allergy Pulm & Crit Care Med, Med Ctr, Nashville, TN USA
[2] Vanderbilt Univ, Ctr Drug Safety & Immunol, Dept Med, Med Ctr, Nashville, TN USA
[3] Murdoch Univ, Inst Immunol & Infect Dis, Murdoch, WA, Australia
来源
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE | 2025年 / 13卷 / 01期
关键词
D O I
10.1016/j.jaip.2024.09.024
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:236 / +
页数:3
相关论文
共 50 条